1. Generics Bulletin
  2. >>Leadership

AAM Departures Lead To Change Of Chair For IGBA

Trio Of Executives Leave US Association, Including IGBA Chair For 2023

 
• By Dave Wallace

The AAM has confirmed the departure of three executives, one of whom had also been serving as chair of the IGBA. As a result, the global generics industry association has brought in a new interim chair, at the same time as the head of one of the industry’s largest players has joined its CEO Advisory Committee.

Revolving Doors Executives Blurred
Three executives have left the AAM, leading the IGBA to seek a new chair • Source: Shutterstock

Three senior executives at the Association for Accessible Medicines have seen their positions eliminated at the industry body as a result of the latest budgetary measures deployed by the US generics and biosimilars association.

The three affected roles are those of Allen Goldberg, the AAM’s senior vice-president for communications; Erik Komendant, the association’s senior vice-president of government affairs; and Jonathan Kimball,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Generics Bulletin